A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

A new study published in the journal PNAS by researchers at the Department of Clinical Neuroscience, Karolinska Institutet, ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

Aurivo’s 'charity of the year' initiative has raised €660,000 for a range of non-profits since the charity partner programme ...

UAE doctors warn that summer heat can worsen health issues. People with neurological and cardiovascular diseases are at ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

As climate-related health challenges continue to rise globally, public awareness and inclusive city planning may become as ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...